Shanghai Traditional Chinese Medicine Technology

Shanghai Traditional Chinese Medicine Technology is a China-based traditional Chinese medicine pharmaceutical engineering company and public service platform located in Shanghai's Zhangjiang biotech cluster. The company was formed through restructuring of the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Technology and focuses on TCM pharmaceutical engineering, technology transfer, health-food development, technical consulting, and related R&D services. It also holds drug manufacturing capabilities for tablets, hard capsules, granules, and TCM extraction, and has been described as a GMP-capable public technical service platform. Publicly visible patent activity suggests work around TCM formulations and extracts for indications such as hyperuricemia, ulcerative colitis, skin cancer, dyslipidemia, and Alzheimer's disease, but no clearly disclosed modern clinical pipeline was identified. The company appears to operate as a private, active, small enterprise rather than a venture-backed clinical-stage biotech.